| Product Name | MF | CAS | Details |
|---|
| Sacubitril intermediates(2R,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-amino-2-methylpentanoate hydrochloride | C20H26ClNO2 | 149690-12-0 | Details |
| Tianeptine sodium salt | C21H24ClN2NaO4S | 30123-17-2 | Details |
| Alogliptin intermediate 3-Methyl-6-Chlorouracil | C5H5ClN2O2 | 4318-56-3 | Details |
| Nicotine Intermediates MYOSMINE | C9H10N2 | 532-12-7 | Details |
| Atracurium besilate API | C65H82N2O18S2 | 64228-81-5 | Details |
| Baloxavir marboxil Intermediates | C17H17N3O4 | 1985607-70-2 | Details |
| Molnupiravir N-1 | C16H23N3O7 | 2346620-55-9 | Details |
| Creatine phosphate disodium salt | C4H11N3NaO5P | 922-32-7 | Details |
| Nafamostat mesylate | C21H25N5O8S2 | 82956-11-4 | Details |
| Osimertinib Mesylate API | C29H37N7O5S | 1421373-66-1 | Details |
| Sacubitril/Valsartan intermediates | C20H25NO3 | 1426129-50-1 | Details |
| Trelagliptin intermediate 2-Bromomethyl-4-fluoro benzonitrile | C8H5BrFN | 421552-12-7 | Details |
| Molnupiravir API | C13H19N3O7 | 2349386-89-4 | Details |
| Baricitinib intermediate 3 | C6H4ClN3 | 3680-69-1 | Details |
| Lapatinib | C29H26ClFN4O4S | 231277-92-2 | Details |
| Alogliptin Base | C18H21N5O2 | 850649-61-5 | Details |
| Cisplatin | Cl2H6N2Pt | 15663-27-1 | Details |
| Tofacitinib Citrate API | C16H20N6O.C6H8O7 | 540737-29-9 | Details |
| Ticagrelor Intermediates4,6-Dichloro-2-propylsulfanyl-pyrimidin-5-ylamine | C7H9Cl2N3S | 145783-15-9 | Details |
| Sorafenib | C21H16ClF3N4O3 | 284461-73-0 | Details |
| Ticagrelor Intermediates 3-Carboxy-2,3-dihydroxy-propionate6-(2-hydroxy-ethoxy)-2,2-dimethyl-tetrahydro-cyclopenta[1,3]dioxol-4- | C14H25NO10 | 376608-65-0 | Details |
| Tenofovir Alafenamide N-2 | C21H29N6O5P | 379270-37-8 | Details |
| Osimertinib N-3 | C20H16FN5O3 | 1421372-94-2 | Details |
| Product Total： Product Page： | ||||
| 1 2 | ||||